Rockwell Medical (RMTI) Current Assets (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Current Assets came in at $36.9 million in Q1 2026, up 11.83% YoY from $33.0 million in Q1 2025, and down 3.2% on a QoQ basis from $38.2 million in Q4 2025.
Rockwell Medical (RMTI) Current Assets (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of Current Assets data on file, last reported at $36.9 million in Q1 2026.
- Quarterly Current Assets rose 11.83% year-over-year to $36.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $36.9 million (up 11.83% YoY) and the FY2025 annual result came in at $38.2 million, up 3.06% from the prior year.
- Current Assets declined to $36.9 million in Q1 2026, from $38.2 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $47.2 million in Q2 2022 to a low of $24.8 million in Q1 2022.
- A 5-year average of $33.5 million and a median of $33.0 million in 2025 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets plunged 58.14% — and 2024, when it advanced 28.71%.
- Tracing RMTI's Current Assets over 5 years: stood at $35.3 million in 2022, then fell by 18.52% to $28.8 million in 2023, then rose by 28.71% to $37.0 million in 2024, then gained by 3.06% to $38.2 million in 2025, then declined by 3.2% to $36.9 million in 2026.
- The last three Current Assets figures came in at $36.9 million (Q1 2026), $38.2 million (Q4 2025), and $37.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.22 Bn |
| 10 | Rockwell Medical | 30.62 Mn | 5.82 Mn | 3.24 Mn | 36.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 36.36 Mn |
| Mar 31, 2026 | 36.94 Mn |
| Dec 31, 2025 | 38.16 Mn |
| Sep 30, 2025 | 37.51 Mn |
| Jun 30, 2025 | 31.61 Mn |
| Mar 31, 2025 | 33.03 Mn |
| Dec 31, 2024 | 37.03 Mn |
| Sep 30, 2024 | 34.22 Mn |
| Jun 30, 2024 | 29.75 Mn |
| Mar 31, 2024 | 26.70 Mn |
| Dec 31, 2023 | 28.77 Mn |
| Sep 30, 2023 | 28.17 Mn |
| Jun 30, 2023 | 27.57 Mn |
| Mar 31, 2023 | 29.69 Mn |
| Dec 31, 2022 | 35.31 Mn |
| Sep 30, 2022 | 42.36 Mn |
| Jun 30, 2022 | 47.25 Mn |
| Mar 31, 2022 | 24.80 Mn |
| Dec 31, 2021 | 35.29 Mn |
| Sep 30, 2021 | 46.08 Mn |